
New Cancer Diagnostic Pathway Service to Launch on Federated Data Platform
New cancer diagnostic pathway service launching in 2025 aims to improve patient care through better data access. π©Ίπ
Discover the newest research about AI innovations in π Oncology.
New cancer diagnostic pathway service launching in 2025 aims to improve patient care through better data access. π©Ίπ
Proteomics and metabolomics are vital in cancer research, revealing insights into tumor biology and potential therapies. π§¬π¬
AI identifies genetic factors linked to Parkinson’s disease, revealing potential drug repurposing opportunities. π§¬π
A new deep learning model enhances skin cancer classification accuracy. π€π Early diagnosis is crucial for effective treatment.
UK invests Β£82.6 million in AI cancer research. Three projects aim to enhance diagnostics and drug discovery. π§¬π°
Antiviral therapy reduces immune-related adverse events in HBV-positive liver cancer patients treated with immunotherapy. ππ
AI enhances personalized cancer treatment by analyzing diverse patient data, improving prognosis accuracy and clinical decision-making. π§¬π€
Next-Generation Sequencing enhances precision medicine in hepatocellular carcinoma, addressing drug resistance and improving treatment outcomes. π§¬π¬
Ensemble learning models show promise in predicting tumor deposits in rectal cancer. π©Ίπ VELM outperforms others with an AUC of 0.875.
Women entrepreneurs excelled at the UK Women in Innovation Awards, showcasing innovative health tech solutions. ππ‘